340B Delayed Regulations on Transparency and CMPs

Sep 21, 2020
AHA General Counsel Melinda Reid Hatton and acclaimed appellate litigator Cate Stetson, a partner at law firm Hogan Lovells, discuss Justice Ginsburg’s contribution to the Supreme Court and justice in America, the legal challenges facing the Affordable Care Act, and lawsuits that could affect…
Feb 28, 2019
Following a December 17, 2018 status conference, the Court issued a minute order requiring defendants to "file [a] status report[] pertaining to their progress in publishing pricing data by not later than February 28, 2019 . . . ." Minute Order, Dec. 18, 2018. Consistent with their representations…
Dec 18, 2018
In a status conference held on December 17, 2018, the parties agreed that, with respect to plaintiffs' principal claims relating to the final 340B Rule, the case is now MOOT.
Nov 30, 2018
As urged by the AHA, the Health Resources and Services Administration today announced that it expects to publish online by April 1 drug ceiling prices under the 340B Drug Pricing Program.
Nov 21, 2018
Memorandum in Opposition to Defendants' Motion to Dismiss and Reply in Support of Summary Judgment Proposed Order Exhibits THE AMERICAN HOSPITAL ASSOCIATION, et al., Plaintiffs, v. THE DEPARTMENT OF HEALTH AND HUMAN SERVICES, et al., Defendants. Case No. 18-2112 (JDB)
Nov 13, 2018
Government’s memorandum, in opposition to our motion for summary judgment and in support of their motion to dismiss Plaintiffs are i) hospitals that buy drugs through a government-created drug discount program known as the 340B Program, and ii) hospital associations whose members allegedly do the…
Nov 7, 2018
In a November 2, 2018 Order, the Court instructed the parties to file, by no later than November 8, 2018, a joint proposed schedule for briefing, plaintiffs' motion for summary judgment and defendants' planned motion to dismiss. Order, ECF No. 19, at 6. The parties conferred and agreed on the…
Nov 2, 2018
Plaintiffs, a collection of hospitals, hospital associations, and healthcare providers, have brought this action against the Department of Health and Human Services (“HHS”) and Secretary of HHS Alex M. Azar II, in his official capacity, arguing that HHS’s decision to continue to delay…